이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Maravai LifeSciences Holdings 관리
관리 기준 확인 4/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Trey Martin
최고 경영자
US$2.3m
총 보상
| CEO 급여 비율 | 32.6% |
| CEO 임기 | less than a year |
| CEO 소유권 | 0.2% |
| 경영진 평균 재임 기간 | 2.1yrs |
| 이사회 평균 재임 기간 | 3.7yrs |
최근 관리 업데이트
Recent updates
RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One
Jun 12Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%
May 14
An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued
Apr 07Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
Feb 28Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price
Dec 19Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates
Aug 14Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?
Feb 28Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 01Maravai Lifesciences temporarily reinstates Carl Hull as CEO
Oct 19Maravai LifeSciences appoints former Danaher executive as CEO
Oct 03Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M
Aug 04Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Jun 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 29Maravai Faces Skeptical Investors As Pandemic Enters New Period
Jan 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price Could Signal Some Risk
Dec 02Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 26% Below Its Share Price
Oct 07CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$131m |
| Dec 31 2023 | US$2m | US$750k | -US$119m |
| Sep 30 2023 | n/a | n/a | US$25m |
| Jun 30 2023 | n/a | n/a | US$75m |
| Mar 31 2023 | n/a | n/a | US$153m |
| Dec 31 2022 | US$15m | US$660k | US$220m |
보상 대 시장: Trey 의 총 보상 ($USD 2.30M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 5.67M ).
보상과 수익: Trey 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Trey Martin (49 yo)
less than a year
테뉴어
US$2,301,864
보상
Mr. William E. Martin, III, also known as Trey, was President of Biologics Safety Testing of Maravai LifeSciences Holdings, Inc. since December 5, 2022 until July 27, 2023 and is its Chief Executive Office...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 3.7yrs | US$5.22m | 0.22% $ 4.0m | |
| Chief Executive Officer | less than a year | US$2.30m | 0.16% $ 2.9m | |
| Executive VP & CFO | 7.2yrs | US$2.79m | 0.022% $ 401.7k | |
| Executive VP & Chief Administrative Officer | 2.1yrs | US$2.83m | 0.030% $ 542.9k | |
| Executive VP & GM of Cygnus Technologies | 6.8yrs | US$2.26m | 0.020% $ 353.5k | |
| President of Nucleic Acid Production | 1.3yrs | US$2.99m | 0.024% $ 434.0k | |
| Senior Director of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Executive VP | 3.7yrs | US$701.40k | 0.019% $ 347.4k | |
| Executive VP & Chief Commercial Officer | 1.4yrs | 데이터 없음 | 0.015% $ 267.3k | |
| Chief Innovation Officer | 1.4yrs | 데이터 없음 | 데이터 없음 |
2.1yrs
평균 재임 기간
55yo
평균 연령
경험이 풍부한 관리: MRVI 의 관리팀은 경험 ( 2 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 3.7yrs | US$5.22m | 0.22% $ 4.0m | |
| Independent Director | less than a year | US$435.03k | 데이터 없음 | |
| Non-Independent Director | 3.7yrs | US$370.48k | 0.0032% $ 58.1k | |
| Non-Independent Director | 3.7yrs | US$367.98k | 0.0032% $ 58.1k | |
| Independent Director | 3.7yrs | US$360.48k | 0.023% $ 422.6k | |
| Independent Director | 3.7yrs | US$395.48k | 0.027% $ 490.4k | |
| Non-Independent Director | 3.7yrs | US$360.48k | 0.0032% $ 58.1k | |
| Non-Independent Director | 3.7yrs | US$360.48k | 0.0032% $ 58.1k | |
| Independent Director | 3.7yrs | US$367.98k | 0.016% $ 282.8k | |
| Independent Director | 3.7yrs | US$387.98k | 0.050% $ 897.9k | |
| Independent Director | 3.7yrs | US$392.98k | 0.012% $ 219.0k |
3.7yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 이사회: MRVI 의 이사회는 경험(평균 재직 기간 3.6 년)으로 간주됩니다.